15.02.2013 Views

world cancer report - iarc

world cancer report - iarc

world cancer report - iarc

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Fig. 5.14 Physician reading digital images of the<br />

breast in preparation for a computer-guided minimally<br />

invasive biopsy.<br />

some parts of South America, especially<br />

Uruguay and Argentina. In contrast, low<br />

rates are found among African and Asian<br />

populations. Amongst population-based<br />

<strong>cancer</strong> registries (as distinct from national<br />

estimates), the 30 recording the highest<br />

rates include 20 registries from North<br />

America, one from South America (Montevideo),<br />

two from Israel and five from<br />

Europe. Amongst this group, the only one<br />

from Africa is for Europeans in Harare. By<br />

contrast, among population-based registries<br />

with the 30 lowest rates, five are<br />

from Africa, 18 from Asia and Israel, three<br />

from South America, two from Eastern<br />

Europe and two from the United States of<br />

America (American Indians in New Mexico<br />

and Koreans in Los Angeles, California)<br />

[2].<br />

These large geographical differences are<br />

potentially explicable on the basis of<br />

genetics or the influences of lifestyle and<br />

environment. Studies of migrant populations<br />

have revealed that when women<br />

migrate from low-risk to high-risk regions,<br />

the migrant populations acquire the rates<br />

of the host country after two or three generations,<br />

indicating lifestyle as primarily<br />

determining the geographic variations in<br />

risk.<br />

“Cumulative incidence” represents the<br />

probability of developing a particular disease<br />

over a life span. Given the uncertainties<br />

of breast <strong>cancer</strong> diagnosis in older<br />

women and the high likelihood of the disease<br />

not being <strong>report</strong>ed in the oldest age<br />

groups, it is common practice to present<br />

cumulative incidence for the age span 0-<br />

74 years. In the <strong>world</strong>, cumulative inci-<br />

dences for breast <strong>cancer</strong> vary from 0.76%<br />

for women in Kangwha, Korea to 11.9% for<br />

non-Hispanic whites in San Francisco,<br />

USA [2].<br />

The absolute number of new breast <strong>cancer</strong><br />

cases <strong>world</strong>wide increased from<br />

572,100 in 1980 to 1,050,346 for the<br />

most recent period [3]. Comparison of<br />

rates rather than absolute figures<br />

excludes change attributable to ageing of<br />

the population as well as differences in<br />

age structures across countries. Even so,<br />

most <strong>cancer</strong> registries of the <strong>world</strong> have<br />

recorded an increase in the incidence of<br />

breast <strong>cancer</strong> over the past 20 years<br />

(Screening for breast <strong>cancer</strong>, p156). In the<br />

period 1975-1990, the largest increases,<br />

greater than 1% and sometimes 5% per<br />

year, are exhibited by registries previously<br />

having low rates of disease, mostly in Asia<br />

and Africa, as well as in some parts of<br />

Europe. In contrast, the smallest increases,<br />

in general inferior to 0.5% per year, are<br />

usually seen in places previously having<br />

high rates, mostly in North America and<br />

Europe. These changes are particularly<br />

obvious in relation to disease in younger<br />

women, that is below 45 years of age<br />

[2,4]. However, mortality rates are falling,<br />

probably due to better treatment (Fig.<br />

5.19).<br />

Etiology<br />

Risk factors for breast <strong>cancer</strong> (Fig. 5.18)<br />

specifically concern the reproductive life<br />

of women. Increased risk is correlated<br />

with early menarche, nulliparity or late age<br />

at first birth, late menopause, as well as<br />

hormonal factors, be they endogenous or<br />

exogenous (e.g. long term use of oral contraceptives<br />

or menopausal hormonal<br />

replacement, Reproductive factors and<br />

hormones, p76). Genetic risk factors are<br />

discussed later (Pathology and genetics).<br />

Other risk factors that may also be mediated<br />

through a hormonal pathway include<br />

obesity and diet, characterized by a high<br />

caloric intake, not counterbalanced by sufficient<br />

physical activity, high total and saturated<br />

animal fat, as well as a diet poor in<br />

fruits and vegetables and rich in meat and<br />

alcohol [5,6]. The role of contaminants,<br />

such as xenoestrogens and certain pesticides,<br />

remains controversial. Radiation, in<br />

Fig. 5.15 Fine needle aspirate of cells from a<br />

breast tumour.<br />

Fig. 5.16 An example of lobular carcinoma in situ,<br />

comprising a well-differentiated malignant proliferation<br />

without signs of invasion.<br />

Fig. 5.17 Infiltrating ductal carcinoma. This is a<br />

poorly-differentiated adenocarcinoma infiltrating<br />

the adipose tissue.<br />

particular at times of breast development,<br />

causes breast <strong>cancer</strong>. Women with epithelial<br />

proliferative lesions, particularly with<br />

atypical ductal or lobular hyperplasia by<br />

comparison with normal histology, have a<br />

four to five times increase in the risk of<br />

developing breast <strong>cancer</strong> [7].<br />

Detection<br />

The commonest presentation of breast<br />

<strong>cancer</strong> is of a painless lump; other symptoms<br />

may include dimpling of the overlying<br />

skin, nipple inversion, oedema or peau<br />

d’orange and blood-stained nipple discharge.<br />

In countries where no mammo-<br />

Breast <strong>cancer</strong><br />

189

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!